Dr. Seyedmohammad Kasaei

Dr. Mohammad Kasaei

Dr. Mohammad Kasaei is an imaging cardiologist with a special interest in Cardiomyopathies and Heart Failure. With over 10 years of experience in the field, Dr. Kasaei completed his Doctor of Medicine degree at the Shiraz University of Medical Sciences in Iran and completed his Cardiology residency program at the same institution. Dr. Kasaei then attended a fellowship course in Cardiovascular Imaging at Shahid Rajaei Cardiovascular and Medical Research Center in Tehran, Iran, where he gained extensive experience in the evaluation and management of a wide spectrum of cardiovascular diseases, including Coronary Artery Diseases, Cardiomyopathies, and Congenital Heart Diseases.

Dr. Kasaei is an experienced Cardiac MRI and Cardiac CT practitioner who has been involved in the management and decision-making of many difficult cases referred by adult and pediatric cardiologists and cardiac surgeons. He has a special interest in the treatment of high blood pressure, lipid disorders, as well as the detection and optimal management of heart failure in its early stages.

As an imaging cardiologist and Heart Team member, Dr. Kasaei provides screening and risk stratification for prevention of cardiac events, manages high blood pressure and blood lipid disorders, and provides emergency care for Acute Cardiac Conditions such as Myocardial Infarction, Heart Failure, and Arrhythmia. He is also experienced in providing standard and guideline-directed care for Ischemic Heart Disease, Heart Failure, and Valvular Heart Disease.

Dr. Kasaei is certified by the Iranian Board of Cardiovascular Diseases and is dedicated to providing high-quality care to his patients.


  • Keramati, A. R., Fathzadeh, M., Go, G.-W., Singh, R., Choi, M., Faramarzi, S., Mane, S., Kasaei, M., Sarajzadeh-Fard, K., Hwa, J., Kidd, K. K., Babaee Bigi, M. A., Malekzadeh, R., Hosseinian, A., Babaei, M., Lifton, R. P., & Mani, A. (2014). A Form of the Metabolic Syndrome Associated with Mutations in DYRK1B . New England Journal of Medicine, 370(20), 1909–1919. https://doi.org/10.1056/NEJMOA1301824
  • Zibaeenezhad, M. J., Ghaem, H., Parsa, N., Sayadi, M., Askarian, M., Kasaei, M., Sohrabi, Z., Dehghani-Firouzabadi, A., Nariman, A., Radmanesh, S., Mani, A., Bahramali, E., Nikoo, M. H., Moaref, A. R., & Razeghian-Jahromi, I. (2019). Analysing cardiovascular risk factors and related outcomes in a middle-aged to older adults population in Iran: a cohort protocol of the Shiraz Heart Study (SHS). BMJ Open, 9(4), e026317. https://doi.org/10.1136/BMJOPEN-2018-026317
  • Nikoo, M. H., Mozaffari, R., Hatamnejad, M. R., Bazrafshan, M., Kasaei, M., & Bazrafshan, H. (2021). Systolic dysfunction and complete heart block as complications of fulminant myocarditis in a recovered COVID-19 patient. Journal of Cardiology Cases, 24(4), 177–181. https://doi.org/10.1016/J.JCCASE.2021.03.009
  • Chenaghlou, M., Kasaei, M., Taghavi, S., Amin, A., & Naderi, N. (2020). Saw tooth cardiomyopathy: a case report. ESC Heart Failure, 7(1), 325–328. https://doi.org/10.1002/EHF2.12574
  • Shojaeifard, M., Saedi, S., Alizadeh Ghavidel, A., Karimlu, M. R., Kasaei, M., Reza Pouraliakbar, H., & Mozaffari, K. (2020). Concomitant cardiac and hepatic hemangiomas. Echocardiography, 37(3), 462–464. https://doi.org/10.1111/ECHO.14614
  • Fathzadeh, M., Keramati, A. R., Go, G., Singh, R., Sarajzadeh, K., Tavakkoly-Bazzaz, J., Noorafshan, A., Kasaei, M., Amini, M., Omrani, G. H. R., Bigi, M. A. B., Babaei, M., Hosseinian, A., Malekzadeh, R., Lifton, R., & Mani, A. (2014). Abstract 20140: Minibrain Relate Kinase / Dyrk1B Links Skeletal Muscle Glycolytic Metabolism with Insulin Resistance and Causes Metabolic Syndrome. Circulation, 130(suppl_2). https://doi.org/10.1161/CIRC.130.SUPPL_2.20140
  • Attar, A., Heydari, M., Abtahi, F., Rezvani, A., Haghighat, S., Vojdani, R., Ramzi, M., Dehghani, M., Karimi, M., Kasaei, M., Khosropanah, S., & Tabandeh, M. (2022). Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial. Cardiology Research and Practice, 2022, 1–7. https://doi.org/10.1155/2022/5681510
  • Fathzadeh, M., Keramati, A. R., Bazzaz, J. T., Yarovinsky, T., Sarajzadeh, K., Amini, M., Noorafshan, A., Mehrabani, D., Dianatpour, M., Omrani, G. H. R., Bigi, M. A. B., Kasaei, M., Poustchi, H., Lifton, R., Malekzadeh, R., & Mani, A. (2015). DYRK1B modifies insulin action in liver and skeletal muscle and predispose to atherosclerosis. Atherosclerosis, 241(1), e23. https://doi.org/10.1016/J.ATHEROSCLEROSIS.2015.04.093
  • Taghavi, S., Alizadeh Sani, Z., Kasaii, M., Keshavarz, M., Naderi, N., Amin, A., Chenaghlou, M., Abshirini, M., & Loghmani, F. (2019). Evaluation of Cardiac Magnetic Resonance Imaging in Heart Failure Patients Suspected of Hypertensive Cardiomyopathy in Rajaie Cardiovascular, Medical, and Research Center Between 2015 and 2017. Iranian Heart Journal, 20(2), 40–46.
  • Samiei, N., Kasaei, M., Salesi, M., & Eftekhari, M. R. (2020). Best Parameter for the Evaluation of Right Ventricular Function by 2D Echocardiography in Patients With Corrected Tetralogy of Fallot. Iranian Heart Journal, 21(3), 40–47.

 Accepted Insurance Companies